MX9100067A - Nuevos usos de l-deprenil y composiciones para los mismos - Google Patents

Nuevos usos de l-deprenil y composiciones para los mismos

Info

Publication number
MX9100067A
MX9100067A MX9100067A MX9100067A MX9100067A MX 9100067 A MX9100067 A MX 9100067A MX 9100067 A MX9100067 A MX 9100067A MX 9100067 A MX9100067 A MX 9100067A MX 9100067 A MX9100067 A MX 9100067A
Authority
MX
Mexico
Prior art keywords
deprenil
themselves
compositions
new uses
deprenyl
Prior art date
Application number
MX9100067A
Other languages
English (en)
Inventor
David R Stevens
Norton W Milgram
Gwendolyn O Ivy
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9100067(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Publication of MX9100067A publication Critical patent/MX9100067A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Thin Film Transistor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Insulating Materials (AREA)
  • Pulse Circuits (AREA)
MX9100067A 1990-08-31 1991-07-02 Nuevos usos de l-deprenil y composiciones para los mismos MX9100067A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US64345291A 1991-01-18 1991-01-18

Publications (1)

Publication Number Publication Date
MX9100067A true MX9100067A (es) 1992-04-01

Family

ID=27076843

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100067A MX9100067A (es) 1990-08-31 1991-07-02 Nuevos usos de l-deprenil y composiciones para los mismos

Country Status (16)

Country Link
US (2) US5276057A (es)
EP (2) EP0732101B1 (es)
JP (3) JP2819072B2 (es)
AT (2) ATE149350T1 (es)
AU (1) AU633714B2 (es)
BR (1) BR9103506A (es)
CA (1) CA2039194C (es)
DE (2) DE69124875T2 (es)
DK (2) DK0473252T3 (es)
ES (2) ES2097790T3 (es)
GR (2) GR3022971T3 (es)
HK (1) HK1011611A1 (es)
ID (1) ID19492A (es)
MX (1) MX9100067A (es)
MY (2) MY124210A (es)
NZ (1) NZ238277A (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
EP0623344B1 (fr) * 1993-05-04 2000-07-26 Ceva Sante Animale Utilisation de la Sélégiline en médecine vetérinaire
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
WO1996022068A2 (en) 1995-01-13 1996-07-25 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
WO1996024346A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
IL122484A0 (en) 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
ES2180809T5 (es) * 1995-11-06 2005-06-16 Somerset Pharmaceuticals, Inc. Administracion de selegilina sublingual y bucal.
AU750909B2 (en) 1998-03-16 2002-08-01 Somerset Pharmaceuticals, Inc. Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
AU2003282337B2 (en) * 2002-11-07 2009-07-16 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
US20050009862A1 (en) * 2003-04-25 2005-01-13 Sabounjian Luann Method for promoting uninterrupted sleep by administration of trospium chloride
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
EP2433626B1 (en) * 2003-11-25 2015-11-04 Technion Research & Development Foundation Ltd. Compositions and methods for treatment of cardiovascular disorders and diseases
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
CA2785521C (en) 2009-12-29 2014-12-02 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
JP6045347B2 (ja) 2010-02-03 2016-12-14 ファーマ ツー ビー リミテッド ラサギリンの持続放出性製剤およびその使用
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same

Also Published As

Publication number Publication date
NZ238277A (en) 1993-10-26
ES2097790T3 (es) 1997-04-16
AU633714B2 (en) 1993-02-04
DE69124875T2 (de) 1997-06-26
MY110217A (en) 1998-03-31
JPH04230624A (ja) 1992-08-19
ATE149350T1 (de) 1997-03-15
ID19492A (id) 1998-07-16
JP2884501B2 (ja) 1999-04-19
CA2039194C (en) 1997-01-28
MY124210A (en) 2006-06-30
EP0732101B1 (en) 1999-06-23
JPH09328422A (ja) 1997-12-22
HK1011611A1 (en) 1999-07-16
GR3022971T3 (en) 1997-06-30
DE69131386D1 (de) 1999-07-29
DK0473252T3 (da) 1997-09-15
BR9103506A (pt) 1992-05-12
ES2135123T3 (es) 1999-10-16
EP0473252A3 (en) 1992-08-05
ATE181501T1 (de) 1999-07-15
EP0473252A2 (en) 1992-03-04
AU7395791A (en) 1992-03-05
CA2039194A1 (en) 1992-03-01
GR3031263T3 (en) 1999-12-31
DK0732101T3 (da) 1999-11-22
JPH09328423A (ja) 1997-12-22
EP0732101A1 (en) 1996-09-18
EP0473252B1 (en) 1997-03-05
US5276057A (en) 1994-01-04
DE69124875D1 (de) 1997-04-10
JP2884500B2 (ja) 1999-04-19
JP2819072B2 (ja) 1998-10-30
DE69131386T2 (de) 1999-11-25
US5387615A (en) 1995-02-07

Similar Documents

Publication Publication Date Title
MX9100067A (es) Nuevos usos de l-deprenil y composiciones para los mismos
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
SE8700203L (sv) Pyroglutamidderivat
DE3851456D1 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
ES2094240T3 (es) Utilizacion de diol diesteres en los alimentos para perros y gatos.
NO882724D0 (no) Smertepreparat.
ES285318Y (es) Tapete perfeccionado para el juego del mus
IT1171125B (it) Composizione per uso orale particolarmente destinata al trattamento terapeutico di animali
ES284524Y (es) Caseta para la cria individual del ternero
ES265781Y (es) "dispositivo para composicion de muebles y estanterias".
ES1002871Y (es) Carro-jaula para el transporte de pequenos animales
BR8806925A (pt) Conjunto de mesas para pequenas centrais
ES280608Y (es) Dispositivo perfeccionado para el cultivo mecanico de la vid
BR8500221A (pt) Cortinado de nylon para cobrir canteiros protegendo assim as plantas das pragas
ES1001196Y (es) Dispositivo perfeccionado para la eliminacion de insectos
BR1100204A (pt) Composição farmacêutica para tratar esquizofrenia
MX4641A (es) Composiciones microbicidas y procedimiento para su preparacion
MX164684B (es) Sustituto de leche para alimentacion animal y procedimiento para preparar el mismo
ES266629Y (es) "aparato para facilitar el traslado y acomodacion de enfermos y minusvalidos".
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
ES1002485Y (es) Criadero termico para ganado

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees